Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP442270.RA7OpnS5oHBm6ej7NunBcuJ9QjmxssDEFJLG6d-0KEYnM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP442270.RA7OpnS5oHBm6ej7NunBcuJ9QjmxssDEFJLG6d-0KEYnM130_assertion type Assertion NP442270.RA7OpnS5oHBm6ej7NunBcuJ9QjmxssDEFJLG6d-0KEYnM130_head.
- NP442270.RA7OpnS5oHBm6ej7NunBcuJ9QjmxssDEFJLG6d-0KEYnM130_assertion description "[The mRNA for RGS9-2 in 29 control hippocampi was 0.185 +/- 0.015 fg per fg of beta-glucuronidase mRNA (average +/- SE), while that in 29 schizophrenia hippocampi was 0.145 +/- 0.015 fg per fg of beta-glucuronidase mRNA (average +/- SE), a reduction of 22%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP442270.RA7OpnS5oHBm6ej7NunBcuJ9QjmxssDEFJLG6d-0KEYnM130_provenance.
- NP442270.RA7OpnS5oHBm6ej7NunBcuJ9QjmxssDEFJLG6d-0KEYnM130_assertion evidence source_evidence_literature NP442270.RA7OpnS5oHBm6ej7NunBcuJ9QjmxssDEFJLG6d-0KEYnM130_provenance.
- NP442270.RA7OpnS5oHBm6ej7NunBcuJ9QjmxssDEFJLG6d-0KEYnM130_assertion SIO_000772 17318883 NP442270.RA7OpnS5oHBm6ej7NunBcuJ9QjmxssDEFJLG6d-0KEYnM130_provenance.
- NP442270.RA7OpnS5oHBm6ej7NunBcuJ9QjmxssDEFJLG6d-0KEYnM130_assertion wasDerivedFrom befree-20150227 NP442270.RA7OpnS5oHBm6ej7NunBcuJ9QjmxssDEFJLG6d-0KEYnM130_provenance.
- NP442270.RA7OpnS5oHBm6ej7NunBcuJ9QjmxssDEFJLG6d-0KEYnM130_assertion wasGeneratedBy ECO_0000203 NP442270.RA7OpnS5oHBm6ej7NunBcuJ9QjmxssDEFJLG6d-0KEYnM130_provenance.